Clinical trial
Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)
NCT00147966 · University of California, San Diego, Other · Completed
Key facts
| NCT number | NCT00147966 |
|---|---|
| Title | Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study) |
| Official title | Assessment of the Immunomodulatory Effects of Rituximab in Seropositive Rheumatoid Arthritis Using Arthroscopic Synovial Biopsies |
| Lead sponsor | University of California, San Diego, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | rituximab |
| Enrollment | 24 |
| Start date | Jun 1, 2008 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 7, 2005 |
| Last update posted | Mar 23, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: